Investor Overview

    

Corporate Profile

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of cardiovascular, metabolic and liver diseases.
NASDAQ MDGL (Common)
$15.60 - 0.05
Stock chart for: MDGL.OQ.  Currently trading at $15.60 with a 52 week high of $18.24 and a 52 week low of $6.60.
Feb 27, 2017 4:00 p.m. ET